Dr. Kathy I. Perez, M.D., MBA, LSSGB, serves as the Chief Operating Officer of IRIS Rheumatology and IRIS Research and Development, where she leads the strategic execution of a robust portfolio of clinical trials spanning autoimmune, inflammatory, and advanced cell therapy research. A physician and seasoned scientific researcher with nearly two decades of experience, she is widely recognized for her innovative approach and leadership in trial design, regulatory strategy, and the development of translational research infrastructure.